ReviewDrug design, development and therapy2020

Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.

Amanda L Blackmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.